Cancer Research · 2008 · 31 citations · 38 references
MedicineMolecular GeneticsOncologyCancer GeneticsMolecular OncologyTumor MicroenvironmentAngiogenesisAngiogenesis In CancerGrowth Factor SignalingOncogenic Signaling PathwaysExtracellular Signal-regulated Kinase SignalingFibroblast Growth Factor Receptor AlterationsHypoxia-inducible Factor RegulationHypoxia-inducible Factor SignalingHypoxia-inducible SignalingVascular Endothelial Growth FactorVascular Endothelial Growth Factor Receptor SignalingVascular Endothelial Growth Factor Signaling
von Hippel-Lindau (VHL) disease results from germline and somatic mutations in the VHL tumor suppressor gene and is characterized by highly vascularized tumors. VHL mutations lead to stabilization of hypoxia-inducible factor (HIF), which up-regulates proangiogenic factors such as vascular endothelial growth factor (VEGF). This pathway is therefore believed to underlie the hypervascular phenotypes of the VHL tumors. However, recent studies have identified novel VHL functions that are independent of the HIF-VEGF pathway. In addition, a potential role of VHL in the tumor microenvironment, which carries heterozygous VHL mutations in VHL patients, has been overlooked. Here, we report a novel HIF-independent VHL function in the endothelium. VHL knockdown in primary human microvascular endothelial cells caused defective turnover of surface fibroblast growth factor (FGF) receptor, increased extracellular signal-regulated kinase signaling, and ETS1 activation, leading to increased cell motility in response to FGF and three-dimensional cord formation in vitro. HIF-alpha knockdown in VHL loss-of-function endothelial cells does not impede their elevated in vitro angiogenic activity. Importantly, the elevated angiogenic response to FGF is recapitulated in Vhl-heterozygous mice. Thus, partial loss of function of VHL in endothelium may be a contributing factor in tumor angiogenesis through a HIF-VEGF-independent mechanism.
38
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Farida Latif, Kálmán Tory, James R. Gnarra et al. · Science · 1993 · 3K citations
Rbx1, a Component of the VHL Tumor Suppressor Complex and SCF Ubiquitin Ligase
Takumi Kamura, Deanna M. Koepp, Michael N. Conrad et al. · Science · 1999 · 787 citations